Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Immunoassay in R D Companies

ID: MRFR/HC/6420-CR
114 Pages
Vikita Thakur
Last Updated: February 16, 2025
Companies specializing in immunoassays within the context of Research and Development (R&D) often play a pivotal role in advancing scientific knowledge, drug discovery, and diagnostic technologies. Immunoassays involve the use of antibodies to detect and measure specific proteins, hormones, or other molecules, making them valuable tools in various R&D applications.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Immunoassay in R D Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.63%
2024 Market Size$ 11.53 Billion
2025 Market Size$ 12.54 Billion
2035 Market Size$ 25.99 Billion
Key Players
Abbott Laboratories
Roche Diagnostics
Siemens Healthineers
Thermo Fisher Scientific
Danaher Corporation
Bio-Rad Laboratories
Opportunities
  • Market Growth Projections
  • Rising Demand for Diagnostic Testing
  • Growing Focus on Personalized Medicine

Top Industry Leaders in the Immunoassay in R D Market

Immunoassays in R&D Key CompaniesLatest Immunoassays in R and D Companies Update
  • Mar 2023: Leading global player in vitro diagnostics, bioMérieux, has invested strategically in Proxim Diagnostics Corp., an innovative business creating a portable point-of-care diagnostic tool. The money will be utilized to finish the development and launch Proxim's Profile System, a fully automated, mobile immunodiagnostic tool that uses disposable cartridges to perform multiplexed tests. Proxim is working on several immunoassays that will match the sensitivity and accuracy of tests conducted on more sophisticated, centralized laboratory equipment in infectious disease, cardiology, and sepsis. The company's portable device is anticipated to enhance the capacity of medical professionals to conduct quick, high-quality assessments at the point of care, such as in emergency rooms, critical care units, assisted living facilities, community/remote clinics, in-home care, and defense and disaster relief scenarios. Right now, the technology can only be used for study.
List of Immunoassays in R and D Key companies in the market
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • Becton
  • Dickinson and Company
  • Danaher Corporation
  • bioMérieux Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • Abcam plc